Overview
A phase 3 study evaluating a one-time investigational cell therapy (bemdaneprocel) on movement, balance, motor symptoms, and quality of life in adults with Parkinson's disease.
Eligibility
Adults with Parkinson's disease
InclusionAdults with Parkinson's disease
Location
Johns Hopkins Medicine, Baltimore, MD
Study Flyer
